Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Technische Universität Dresden
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Travera Inc
Asan Medical Center
Eastern Cooperative Oncology Group
Molecular Partners AG
Turning Point Therapeutics, Inc.
Moonlight Bio, Inc
H. Lee Moffitt Cancer Center and Research Institute
Boston Scientific Corporation
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
The First Affiliated Hospital of Xiamen University
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Florida
Intergroupe Francophone de Cancerologie Thoracique
SystImmune Inc.
IDEAYA Biosciences
Hospices Civils de Lyon
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
TaiRx, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
University of Iowa
University of Miami
M.D. Anderson Cancer Center
Tanabe Pharma America, Inc.
UNICANCER
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Wren Laboratories LLC
National Institutes of Health Clinical Center (CC)
AbbVie
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire Dijon
Latin American Cooperative Oncology Group
Phanes Therapeutics
Vyriad, Inc.
Circle Pharma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Hospices Civils de Lyon
Fudan University
AHS Cancer Control Alberta
Case Comprehensive Cancer Center
Radio Isotope Therapy of America
Fox Chase Cancer Center